{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?sponsor=The+University+of+Texas+at+Arlington", "query": { "sponsor": "The University of Texas at Arlington" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 46, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?sponsor=The+University+of+Texas+at+Arlington&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T02:06:40.418Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03679780", "title": "The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cardiovascular Diseases", "Cardiovascular Risk Factor", "Vasoconstriction" ], "interventions": [ { "name": "BQ-788", "type": "DRUG" }, { "name": "BQ-123", "type": "DRUG" }, { "name": "L-Arginine", "type": "DRUG" }, { "name": "NG Nitro L Arginine Methyl Ester", "type": "DRUG" }, { "name": "Sodium Nitroprusside", "type": "DRUG" }, { "name": "Lactated Ringer's", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas at Arlington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 19, "start_date": "2018-10-01", "completion_date": "2023-07-26", "has_results": false, "last_update_posted_date": "2024-06-11", "last_synced_at": "2026-09-02T02:06:40.418Z", "location_count": 1, "location_summary": "Arlington, Texas", "locations": [ { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03679780" }, { "nct_id": "NCT00952900", "title": "An Implementation and Biobehavioral Study of Temporomandibular Joint and Muscle Disorder (TMJMD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Temporomandibular Joint and Muscle Disorder" ], "interventions": [ { "name": "Biobehavioral", "type": "BEHAVIORAL" }, { "name": "Active Coping/Attention Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "The University of Texas at Arlington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 456, "start_date": "2008-08", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2015-06-08", "last_synced_at": "2026-09-02T02:06:40.418Z", "location_count": 1, "location_summary": "Arlington, Texas", "locations": [ { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00952900" }, { "nct_id": "NCT07783061", "title": "Reducing Cardiovascular Risks: The Role of Alcohol Use", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alcohol Drinking", "Drinking Behavior", "At-risk Drinking", "Cardiovascular Risk Factor", "High Blood Pressure" ], "interventions": [ { "name": "Alcohol Abstinence", "type": "BEHAVIORAL" }, { "name": "Control arm", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "The University of Texas at Arlington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "26 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "26 Years to 49 Years" }, "enrollment_count": 148, "start_date": "2026-10", "completion_date": "2031-09", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-09-02T02:06:40.418Z", "location_count": 1, "location_summary": "Arlington, Texas", "locations": [ { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07783061" }, { "nct_id": "NCT04671966", "title": "Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Heart Diseases", "Left Ventricular Dysfunction" ], "interventions": [ { "name": "Estradiol patch", "type": "DRUG" }, { "name": "Cetrotide", "type": "DRUG" }, { "name": "Fasting", "type": "OTHER" }, { "name": "Lower Body Negative Pressure", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "The University of Texas at Arlington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "18 Years to 30 Years" }, "enrollment_count": 100, "start_date": "2018-09-13", "completion_date": "2024-12", "has_results": false, "last_update_posted_date": "2024-02-20", "last_synced_at": "2026-09-02T02:06:40.418Z", "location_count": 1, "location_summary": "Arlington, Texas", "locations": [ { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04671966" }, { "nct_id": "NCT06330649", "title": "The Acute Effect of and Energy Drink vs. Water Consumption on MAP, HR, and Energy Metabolism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cardiovascular Diseases", "Hypertension", "Diet" ], "interventions": [ { "name": "Energy Drink", "type": "DIETARY_SUPPLEMENT" }, { "name": "Water Control", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "The University of Texas at Arlington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "18 Years to 30 Years" }, "enrollment_count": 32, "start_date": "2024-01-01", "completion_date": "2024-09-01", "has_results": false, "last_update_posted_date": "2025-04-01", "last_synced_at": "2026-09-02T02:06:40.418Z", "location_count": 1, "location_summary": "Arlington, Texas", "locations": [ { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06330649" }, { "nct_id": "NCT03684213", "title": "Local Antioxidant Therapy Vasoconstriction Effects in Different Races", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cardiovascular Diseases", "Cardiovascular Risk Factor", "Vasoconstriction" ], "interventions": [ { "name": "Control (Norepinephrine)", "type": "DRUG" }, { "name": "Norepinephrine + Ascorbic Acid", "type": "DRUG" }, { "name": "Norepinephrine + L-NAME", "type": "DRUG" }, { "name": "Norepinephrine + L-NAME + Ascorbic Acid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas at Arlington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 22, "start_date": "2018-10-15", "completion_date": "2024-06-08", "has_results": false, "last_update_posted_date": "2024-06-11", "last_synced_at": "2026-09-02T02:06:40.418Z", "location_count": 1, "location_summary": "Arlington, Texas", "locations": [ { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03684213" }, { "nct_id": "NCT03680404", "title": "The Effect of Local Antioxidant Therapy on Racial Differences in Vasoconstriction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cardiovascular Diseases", "Cardiovascular Risk Factor", "Vasoconstriction" ], "interventions": [ { "name": "Control (Phenylephrine)", "type": "DRUG" }, { "name": "Phenylephrine + Apocynin", "type": "DRUG" }, { "name": "Phenylephrine + Allopurinol", "type": "DRUG" }, { "name": "Phenylephrine + Tempol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas at Arlington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 24, "start_date": "2018-10-01", "completion_date": "2020-02-01", "has_results": false, "last_update_posted_date": "2020-11-05", "last_synced_at": "2026-09-02T02:06:40.418Z", "location_count": 1, "location_summary": "Arlington, Texas", "locations": [ { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03680404" }, { "nct_id": "NCT00957164", "title": "Treatment of Post-Traumatic Stress Disorder (PTSD) and Chronic Pain After Traumatic Orthopedic Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Pain", "Post-traumatic Stress Disorder" ], "interventions": [ { "name": "Brief Prolonged Exposure Protocol", "type": "BEHAVIORAL" }, { "name": "Chronic Pain Management Treatment", "type": "BEHAVIORAL" }, { "name": "Self-Care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "The University of Texas at Arlington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 51, "start_date": "2009-08", "completion_date": "2013-09", "has_results": false, "last_update_posted_date": "2014-01-31", "last_synced_at": "2026-09-02T02:06:40.418Z", "location_count": 4, "location_summary": "Arlington, Texas • Fort Sam Houston, Texas • Lackland Air Force Base, Texas + 1 more", "locations": [ { "city": "Arlington", "state": "Texas" }, { "city": "Fort Sam Houston", "state": "Texas" }, { "city": "Lackland Air Force Base", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00957164" }, { "nct_id": "NCT03471117", "title": "Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Kidney Diseases" ], "interventions": [ { "name": "Pioglitazone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "The University of Texas at Arlington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "35 Years to 70 Years" }, "enrollment_count": 5, "start_date": "2018-04-01", "completion_date": "2020-01-14", "has_results": true, "last_update_posted_date": "2026-07-27", "last_synced_at": "2026-09-02T02:06:40.418Z", "location_count": 2, "location_summary": "Arlington, Texas • Dallas, Texas", "locations": [ { "city": "Arlington", "state": "Texas" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03471117" }, { "nct_id": "NCT01082536", "title": "Analysis of Cerebral Perfusion Using Head Ultrasound and Multisource Detector Near Infrared Spectroscopy (NIRS) Imaging", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Congenital Heart Disease" ], "interventions": [], "intervention_types": [], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "2 Months", "sex": "ALL", "summary": "Up to 2 Months" }, "enrollment_count": 0, "start_date": "2013-03-28", "completion_date": "2019-05", "has_results": false, "last_update_posted_date": "2019-01-31", "last_synced_at": "2026-09-02T02:06:40.418Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01082536" } ] }